We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$817M
AUM Growth
-$36.2M
Cap. Flow
-$39.4M
Cap. Flow %
-4.82%
Top 10 Hldgs %
12.04%
Holding
1,060
New
418
Increased
118
Reduced
111
Closed
413

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$12.8M
2
CRM icon
Salesforce
CRM
+$9.18M
3
NKE icon
Nike
NKE
+$8.85M
4
DHR icon
Danaher
DHR
+$8.43M
5
AMZN icon
Amazon
AMZN
+$8.08M

Top Sells

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$17.9M
2
TSLA icon
Tesla
TSLA
+$16.6M
3
CVX icon
Chevron
CVX
+$15.3M
4
MDB icon
MongoDB
MDB
+$9.4M
5
FTNT icon
Fortinet
FTNT
+$8.82M

Sector Composition

Rank Sector Weight
1 Technology 22.57%
2 Consumer Discretionary 15.97%
3 Healthcare 14.57%
4 Industrials 11.33%
5 Financials 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMMR icon
601
Immersion
IMMR
$253M
$129K 0.02%
+14,813
New +$129K
GENI icon
602
Genius Sports
GENI
$2.24B
$129K 0.02%
+14,900
New +$124K
OSG
603
Octave Specialty Group
OSG
$210M
$127K 0.02%
+10,076
New +$121K
RKT icon
604
Rocket Companies
RKT
$39.3B
$125K 0.02%
+11,100
New +$165K
PHAT icon
605
Phathom Pharmaceuticals
PHAT
$733M
$121K 0.01%
+14,900
New +$185K
STGW icon
606
Stagwell
STGW
$2.16B
$116K 0.01%
+17,680
New +$126K
VISN
607
Vistance Networks Inc
VISN
$1.4B
$115K 0.01%
22,100
+4,500
+26% +$25.2K
VET icon
608
Vermilion Energy
VET
$1.91B
$114K 0.01%
+12,100
New +$118K
NWG icon
609
NatWest
NWG
$73B
$113K 0.01%
11,124
-42,200
-79% -$418K
ALT icon
610
Altimmune
ALT
$599M
$106K 0.01%
+14,700
New +$112K
WOOF icon
611
Petco
WOOF
$768M
$96K 0.01%
+25,200
New +$114K
CHPT icon
612
ChargePoint
CHPT
$143M
$92.8K 0.01%
+4,335
New +$107K
STKL
613
DELISTED
SunOpta
STKL
$88.8K 0.01%
11,536
+1,523
+15% +$10.8K
GGB icon
614
Gerdau
GGB
$8.97B
$85.5K 0.01%
+29,700
New +$98.1K
RLX icon
615
RLX Technology
RLX
$2.24B
$82.3K 0.01%
+38,100
New +$68.5K
NNOX icon
616
Nano X Imaging
NNOX
$63.7M
$81.4K 0.01%
+11,300
New +$72.3K
LFST icon
617
Lifestance Health
LFST
$4.76B
$81.2K 0.01%
11,011
-11,000
-50% -$78.9K
TMCI icon
618
Treace Medical Concepts
TMCI
$299M
$77.4K 0.01%
+10,403
New +$69.6K
VLRS
619
Controladora Vuela Compania de Aviacion
VLRS
$775M
$76.5K 0.01%
10,287
-6,800
-40% -$50.9K
CGC
620
Canopy Growth
CGC
$449M
$75.3K 0.01%
+27,500
New +$109K
BBD icon
621
Banco Bradesco
BBD
$34.1B
$75.3K 0.01%
39,400
+15,885
+68% +$37.2K
TK icon
622
Teekay
TK
$1.14B
$72.7K 0.01%
+10,485
New +$80.9K
MPT
623
Medical Properties Trust
MPT
$2.44B
$66.4K 0.01%
+16,800
New +$75.2K
OPEN icon
624
Opendoor
OPEN
$3.22B
$64.3K 0.01%
+41,540
New +$75.3K
LICY
625
DELISTED
Li-Cycle Holdings Corp.
LICY
$64K 0.01%
+35,778
New +$77.2K

Similar funds

Bayesian Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Bayesian Capital Management held 1,060 positions worth $817M, down 4.2% from $853M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bayesian Capital Management withdrew a net $39.4M in Q4 2024, closing 413 positions and reducing 111 holdings. Its most notable exit was Netflix, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in Amgen worth $11.2M.

  • Bayesian Capital Management's largest Q4 2024 buy was Amgen: 43,000 shares worth $11.2M.
  • Bayesian Capital Management added most to Nike in Q4 2024, an estimated $8.85M increase.
  • Bayesian Capital Management's biggest Q4 2024 reduction was Tesla, cutting an estimated $16.6M.
  • Bayesian Capital Management fully exited Netflix in Q4 2024, selling an estimated $17.9M.
  • Bayesian Capital Management's ten largest holdings make up 12% of its $817M portfolio in Q4 2024.
  • Bayesian Capital Management opened 418 new positions and closed 413 in Q4 2024.
  • Bayesian Capital Management's portfolio value fell 4.2% quarter-over-quarter to $817M.

Based on Bayesian Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.